Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions.
about
Curcumin and HealthHigh-Risk Cardiovascular Patients: Clinical Features, Comorbidities, and Interconnecting MechanismsInteractions between muscle stem cells, mesenchymal-derived cells and immune cells in muscle homeostasis, regeneration and diseaseManagement of cardiovascular disease in patients with psoriasis.IRF5 deficiency ameliorates lupus but promotes atherosclerosis and metabolic dysfunction in a mouse model of lupus-associated atherosclerosisEpigenetic regulation of inflammatory cytokines and associated genes in human malignanciesImpact of long-term steroid therapy on epicardial and pericardial fat deposition: a cardiac MRI studyEndothelial Dysfunction in Rheumatoid Arthritis: Mechanistic Insights and Correlation with Circulating Markers of Systemic Inflammation.Is urate crystal precipitation a predictor of cardiovascular risk in hyperuricemic patients? A Danish cohort study.Relationship of Genetic Polymorphisms of the Chemokine, CCL5, and Its Receptor, CCR5, with Coronary Artery Disease in Taiwan.The Effects of Rituximab on Lipids, Arterial Stiffness and Carotid Intima-Media Thickness in Rheumatoid ArthritisIncreased Long-Term Cardiovascular Risk After Total Hip Arthroplasty: A Nationwide Cohort StudySpecific cell-derived microvesicles: Linking endothelial function to carotid artery intima-media thickness in low cardiovascular risk menopausal women.Leukocytes Link Local and Systemic Inflammation in Ischemic Cardiovascular Disease: An Expanded "Cardiovascular Continuum".Impact of Sensory Impairments on Functional Disability in Adults With Arthritis.Short- and Long-term Outcomes in Patients with Connective Tissue Diseases Undergoing Percutaneous Coronary Intervention.Evaluation of Early Atherosclerosis Markers in Patients with Inflammatory Bowel Disease.Expansions of Cytotoxic CD4+CD28- T Cells Drive Excess Cardiovascular Mortality in Rheumatoid Arthritis and Other Chronic Inflammatory Conditions and Are Triggered by CMV Infection.Medicinal plants with anti-inflammatory activities.Applying nanomedicine in maladaptive inflammation and angiogenesis.Inflammation - Cause or Consequence of Heart Failure or Both?Cardiovascular and type 2 diabetes morbidity and all-cause mortality among diverse chronic inflammatory disorders.Coronary microvascular dysfunction in chronic inflammatory rheumatoid diseases.LSD1 inhibitors: a patent review (2010-2015).Rosuvastatin slows progression of subclinical atherosclerosis in patients with treated HIV infection.Management of Cardiovascular Risk in Patients with Chronic Inflammatory Diseases: Current Evidence and Future Perspectives.Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink.Genetic variation associated with cardiovascular risk in autoimmune diseasesSoluble glycoprotein VI, a specific marker of platelet activation is increased in the plasma of subjects with seropositive rheumatoid arthritis.Relationship between Neutrophil-to-Lymphocyte Ratio and Pulse Wave Velocity in Young Patients with Systemic Lupus Erythematosus.Association between sarcoidosis, pulse wave velocity, and other measures of subclinical atherosclerosis: a systematic review and meta-analysis.The association of dietary inflammatory potential with depression and mental well-being among U.S. adults.Assessment of cardiovascular risk profile based on measurement of tophus volume in patients with gout.Protective role of the co-stimulator CD27 receptor and regulatory T cells in early atherogenesis.Associations between Food Security Status and Dietary Inflammatory Potential within Lower-Income Adults from the United States National Health and Nutrition Examination Survey, Cycles 2007 to 2014.Frontiers of Prevention: Pollution, Infection, Cognitive Function and Frailty.Long-term outcomes in patients with rheumatologic disorders undergoing percutaneous coronary intervention: a BAsel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination (BASKET-PROVE) sub-study.Immune-Mediated Heart Disease.Long Non-Coding RNAs in Vascular Inflammation.Increased global arterial and subcutaneous adipose tissue inflammation in patients with moderate-to-severe psoriasis.
P2860
Q26765493-761C7E64-67E5-47CB-846B-B7DEFB1B154CQ26774658-2297E5FC-E4AC-4FE0-96D6-62407D0FE181Q26800192-CE208E5C-10FA-43E6-B9A1-1503734C51D1Q30250278-58E19658-D5DF-46B1-A1E7-FBB79B5BFD45Q35070231-6131CFE6-273A-4FA7-99AA-9BBBEE94B996Q35178132-AE6DFF81-AA4D-4493-AE9F-D6CD5FE6CBF3Q35792277-A554D14E-E210-44B9-B1E3-D24C5DA41D92Q35892871-E329D70A-D9B1-4CBE-A63C-A2821C94B343Q36233048-6A8DEAE1-03D5-4FAF-A0C9-FE7E36919D69Q36353087-361535CF-437F-4107-B6C7-661C6AD464B6Q36509932-3F9F3777-A0FE-4751-88FF-2C7CCEAF7FF3Q36580903-04613154-89DD-4BC1-9A7C-C8153DE00321Q36609707-CDCD4E2C-7403-4127-9AEC-E02AF03CDAD3Q36654171-C15A272F-DF65-4FF3-A260-6CB64EFA66BDQ36711703-4E55DD56-81AD-4721-9EF8-6F055951AD14Q36760972-80BDDB0A-FC0B-4CBD-9C71-DA9A2F5A91EFQ37391667-6AC4E438-0CB1-47F2-A9B0-48F776BB47E0Q37675607-3EED963F-DB58-4C64-AACD-67D060EB30D0Q38556732-7178352D-E61F-4664-BF8A-0E10C8EE51A5Q38557650-DDB9C2F1-D97D-492F-B001-96DD07B4FF33Q38664204-23EF55F1-0F1A-4734-828D-164B1F0B2D83Q38732135-31182289-9F8A-40E7-A7FD-E3ADDD5DBB12Q38749160-B14029E9-7A03-4B08-B22F-6DC76DF766B6Q38790899-90C07801-8213-4611-AF7A-2328B9627928Q38864670-D6E01BBF-F576-4B94-8589-FB6F5D85B644Q38972344-4B4F100B-E9E1-4F15-AD63-39D4DE5F4837Q40384936-69B4ECB4-D5E6-45C0-83D6-3A9786EAD245Q42370776-DB2FF2FD-B98B-4EEB-B5C3-AC6556A56090Q47153382-26335105-C45A-4770-9C8F-5BD751342AC6Q47260542-81D638B8-A4E9-411F-9C60-A0A627377348Q47410588-02B186BF-7B02-4D14-882B-2FA39DD29063Q47766679-AD04C4E0-CF5A-4385-AF5B-7D721DD9CBDCQ49484474-AC049B4C-47E1-424F-BDB5-DF3AD34A8D60Q49574295-FF2AD121-1844-45A1-A9AD-A3860F2C205BQ49917560-35F9FE86-D6B9-4705-BC16-66A313696B35Q49959762-056E8C2A-4C27-4598-BB21-F41E25327911Q50899648-90EF6F42-6D69-4A17-A388-3329A2FEE1B4Q51835838-23F48175-C204-4B2E-825F-D6A3EE71B947Q52584216-3E3A4977-A143-49F5-A185-33FD5F1235D8Q52965339-E56809E4-9717-4A74-A015-631177B7AA63
P2860
Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Cardiovascular disease in pati ...... s in rheumatologic conditions.
@ast
Cardiovascular disease in pati ...... s in rheumatologic conditions.
@en
type
label
Cardiovascular disease in pati ...... s in rheumatologic conditions.
@ast
Cardiovascular disease in pati ...... s in rheumatologic conditions.
@en
prefLabel
Cardiovascular disease in pati ...... s in rheumatologic conditions.
@ast
Cardiovascular disease in pati ...... s in rheumatologic conditions.
@en
P2860
P356
P1476
Cardiovascular disease in pati ...... s in rheumatologic conditions.
@en
P2093
Justin C Mason
P2860
P304
P356
10.1093/EURHEARTJ/EHU403
P50
P577
2014-11-27T00:00:00Z